Elevance Health (ELV) Depreciation and Depletion (2010 - 2019)

Elevance Health (ELV) has 10 years of Depreciation and Depletion data on file, last reported at $38.0 million in Q4 2019.

• Quarterly Depreciation and Depletion rose 18.75% year-over-year to $38.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $147.0 million (up 18.55% YoY) and the FY2025 annual result came in at $94.0 million, down 10.48% from the prior year.
• Depreciation and Depletion steadied at $38.0 million in Q4 2019 per ELV's latest filing, from $38.0 million in the prior quarter.
• Across five years, Depreciation and Depletion topped out at $38.0 million in Q3 2019 and bottomed at $25.1 million in Q1 2015.
• The 5-year median for Depreciation and Depletion is $27.8 million (2015), against an average of $29.6 million.
• The widest annual swing landed in 2015, when Depreciation and Depletion decreased 6.67%; it then gained 22.58% in 2019.
• Tracing ELV's Depreciation and Depletion over 5 years: stood at $27.8 million in 2015, then dropped by 5.4% to $26.3 million in 2016, then grew by 10.27% to $29.0 million in 2017, then advanced by 10.34% to $32.0 million in 2018, then rose by 18.75% to $38.0 million in 2019.
• Per Business Quant, the three latest ELV Depreciation and Depletion figures stand at $38.0 million (Q4 2019), $38.0 million (Q3 2019), and $37.0 million (Q2 2019).

Peer Comparison